| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,273,100 | 1,263,600 | 1,094,300 | 1,060,800 | 1,299,000 |
| Cost of Revenue
|
-577,400 | -577,600 | -512,900 | -552,900 | -732,700 |
|
Gross Profit
|
695,600 | 686,000 | 581,400 | 507,900 | 566,200 |
| Selling, General and Administrative Expenses
|
-565,100 | -520,900 | -488,600 | -494,900 | -621,800 |
| Other Income/Expense, Operating
|
500 | 500 | 400 | 700 | 1,000 |
|
Operating Income/Expenses
|
-565,100 | -520,400 | -488,200 | -494,200 | -620,800 |
|
Total Operating Profit/Loss
|
130,500 | 165,600 | 93,200 | 13,700 | -54,600 |
| Total Net Finance Income/Expense
|
-10,000 | -9,900 | -12,100 | -14,400 | -12,800 |
| Net Investment Income
|
-1,300 | -1,300 | 1,200 | -1,600 | -4,200 |
| Irregular Income/Expenses
|
0 | -- | 0 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
-10,000 | -11,200 | -10,900 | -16,000 | -17,000 |
|
Pretax Income
|
120,500 | 154,500 | 82,300 | -2,300 | -71,600 |
|
Provision for Income Tax
|
3,900 | 14,100 | 1,100 | 800 | -100 |
|
Net Income from Continuing Operations
|
124,300 | 168,500 | 83,400 | -1,500 | -71,700 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
124,300 | 168,500 | 83,400 | -1,500 | -71,700 |
|
Net Income after Non-Controlling/Minority Interests
|
124,300 | 168,500 | 83,400 | -1,500 | -71,700 |
|
Net Income Available to Common Stockholders
|
124,300 | 168,500 | 83,400 | -1,500 | -71,700 |
|
Diluted Net Income Available to Common Stockholders
|
124,300 | 168,500 | 83,400 | -1,500 | -71,700 |
| Basic EPS
|
4.14 | 5.62 | 2.78 | -0.06 | -3.32 |
| Diluted EPS
|
4.14 | 5.62 | 2.78 | -0.06 | -3.32 |
|
Basic Weighted Average Shares Outstanding
|
30,011.10 | 30,011.10 | 29,972.95 | 26,129.48 | 21,599.09 |
|
Diluted Weighted Average Shares Outstanding
|
30,011.10 | 30,011.10 | 29,972.95 | 26,129.48 | 21,599.09 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
130,500 | 164,300 | 94,000 | 12,000 | -58,900 |
|
EBITDA
|
192,200 | 219,600 | 146,500 | 60,500 | -14,900 |
|
Normalized EBITDA
|
192,200 | 219,600 | 146,500 | 59,200 | -12,300 |
|
Normalized Income
|
124,300 | 168,500 | 83,400 | -2,333.30 | -69,635.60 |
|
Total Unusual Items
|
0 | 0 | 0 | -1,300 | 2,600 |
|
Total Unusual Items Excluding Goodwill
|
0 | 0 | 0 | -1,300 | 2,600 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | -466.70 | 535.60 |
12/31/2022 - 12/17/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade